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Abstract Primary hyperparathyroidism (pHPT) is almost
exclusively the result of a solitary parathyroid adenoma. In
most cases, the affected gland can be surgically removed,
but precise preoperative imaging is essential for adenoma
localization prior to surgical intervention. In this study, we
evaluated the diagnostic value of four-dimensional com-
puted tomography (4D-CT) as a preoperative imaging tool
in relation to the localization of pathologic parathyroid
glands in patients with pHPT and negative sestamibi scans.
This study included 43 consecutive patients with pHPT
referred for parathyroidectomy at the Department of Head
and Neck Surgery of Copenhagen University Hospital
Rigshospitalet in 2011 and 2012. All patients had a 4D-CT
performed prior to parathyroidectomy. CT localization of
the suspected adenoma was correlated to the actual surgical
findings and subsequent histological diagnosis was also
available as references for the accuracy of this imaging
tool. Hyperfunctioning parathyroid glands were found in
40 patients. 4D-CT identified 32 solitary hyperfunctioning
parathyroid glands located on the correct side of the neck
(PPV 76 %) and 21 located within the correct quadrant
(PPV 49 %). Unilateral resection was performed in 72 %
of patients due to the localization findings of preoperative
imaging. 4D-CT can, therefore, be considered an effective
method for the preoperative localization of parathyroid
adenomas and is an important tool in surgical intervention
for patients referred to parathyroidectomy.
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Introduction
Primary hyperparathyroidism (pHPT) is defined as an au-
tonomous overproduction of parathyroid hormone (PTH).
This overproduction is in approximately 80–90 % of cases
caused by a solitary parathyroid adenoma and in most other
cases by diffuse hyperplasia, rare multiple adenomas or
carcinoma [1]. Parathyroidectomy is the only curative
treatment for pHPT, whether caused by adenoma or hy-
perplasia. The conventional surgical method consists of
bilateral neck exploration with identification of all four
parathyroid glands and resection of hyperfunctioning
glands with pathological appearance [2]. In a majority of
patients with pHPT, unilateral and focused surgical ap-
proaches are sufficient. Benefits of minimizing the extent
of the surgical intervention are reduction in surgical trauma
giving fewer complications, better cosmetic results, shorter
hospitalization and convalescence, and better postoperative
conditions for potential future operations in the thyroid
region [1, 3–5]. To guide these focused surgical interven-
tions, precise preoperative imaging is essential, showing
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the accurate localization of abnormal parathyroid glands.
The commonly used parathyroid imaging technique is
technetium-99 m sestamibi scintigraphy often comple-
mented by ultrasound and in some cases CT or MRI [6].
Sestamibi scans are false negative or inconclusive in ap-
proximately 20 % of all patients, resulting in the need for
other diagnostic imaging methods [3, 7, 8]. In 2006, a
relatively new preoperative imaging modality was intro-
duced called four-dimensional computerized tomography
(4D-CT) [9]. 4D-CT is made up of a series of CT scans
taken at different stages of enhancement and washout of
contrast media in the parathyroid glands. In addition to a
three-dimensional presentation of the anatomical localiza-
tion of the glands, 4D-CT includes a time-dependent con-
trast enhancement of the gland as the ‘‘fourth dimension’’.
The fact, that the parathyroid glands and parathyroid ade-
nomas receives contrast-enhanced blood a few seconds
earlier than the thyroid tissue combined with a slightly
higher flow, makes the adenomas to ‘‘lighten up’’ earlier
the normal thyroid tissue, and also washes the contrast out
earlier. That is the reason for the time-related re-scan of the
area. If you look at the arterial anatomy, all four normal
parathyroid glands get their arterial from the first side-
branch of the thyroid arteries, this may explain why they
receive the contrast a few seconds before the rest of the
thyroid gland. The aim of this study was to evaluate the
diagnostic value of 4D-CT as a preoperative imaging tool
in relation to the localization of pathologic parathyroid
glands in patients with pHPT and negative sestamibi scans.
Patients and methods
This retrospective study includes all patients that in 2011
and 2012 were referred to the Department of Head and
Neck Surgery at the Copenhagen University Hospital
Rigshospitalet for surgical treatment of biochemically
proven primary hyperparathyroidism, as confirmed by
ionized plasma calcium levels [1.32 mmol/L and not
suppressed PTH. All patients presented with negative ses-
tamibi scans and subsequently underwent preoperative 4D-
CT scans at the Department of Radiology at Copenhagen
University Hospital Gentofte, followed by elective
parathyroidectomy in the period from March 2011 to
November 2012.
4D-CT scan technique
4D-CT was performed with 64-slice multidetector scanner
(Philips Brilliance) with each examination consisting of
five continuous helical acquisitions from the mandibular
angle to 2 cm below the most inferior pulmonary apex.
After precontrast scan, 100 ml non-ionic contrast medium
was injected (Omnipaque 300 mgI/mL, GE Healthcare)
with 3.5 mL/s via intravenous access in the right cubital
vein, followed by arterial, portal vein, venous and late
venous contrast helical series, respectively, 22, 52 s for 82
and 122 s after the beginning of contrast injection. Scan
parameters: 120 kV, 200 mAs, pitch 0.671, rotation time
0.75 s, slice thickness 1 mm, increment 0.5 mm collima-
tion 64 9 0.625, window (C/W) 40/350. All 4D-CT scan
images were evaluated on a diagnostic screen and de-
scribed by an experienced specialist in diagnostic radi-
ology. The pathological parathyroid glands were identified
by their pattern of time-related contrast enhancement and
anatomical structure, mainly the size. Scan results were
preoperatively discussed with the surgeon.
Surgical procedure
All surgical procedures were carried out by one of the two
specialists experienced in parathyroid surgery. Abnormal
parathyroid glands were removed based on the surgeon’s
assessment of gland size and shape. After removal of a
gland with pathological appearance, an intraoperative
parathyroid hormone (IOPTH) measurement was used to
confirm the complete resection of abnormally secreting
parathyroid tissue. IOPTH decrease[50 % within 10 min
after resection suggested confirmation in the removal of the
hyperfunctioning parathyroid tissue [10]. All dissections
were initiated unilaterally corresponding to the quadrant
where the 4D-CT revealed a suspicious process. In cases
where an abnormal parathyroid gland was seen and re-
moved, an IOPTH measurement was performed. If IOPTH
decreased sufficiently, the surgery was finished. If either
the 4D-CT described gland was found with normal ap-
pearance, or an insufficient fall in the IOPTH measurement
was reported after excision, the surgical exploration was
expanded until either a gland with pathological appearance
was found and removed resulting in a subsequent sufficient
IOPTH drop, or until all four quadrants were explored.
Histopathological analysis and biochemistry
Preoperative and postoperative serum calcium and PTH
were tested. Surgically removed parathyroid glands were
weighted and histopathologically examined to confirm
hyperfunctioning parathyroid tissue.
Analysis
Diagnostic accuracy measures were used to evaluate the
clinical performance of 4D-CT imaging studies by com-
paring the results of 4D-CT with peroperative findings and
the histopathological diagnosis as a reference standard.
Localization of suspicious parathyroid glands on 4D-CT
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and of surgically removed glands was reported as side
(right or left) and quadrant (right upper, right lower, left
upper, left lower) of the neck. The standard of reference for
the final anatomic location of histologically hyperfunc-
tioning parathyroid gland was the site and quadrant deter-
mined at surgery.
4D-CT imaging results were classified as true positive,
false positive or negative based on correlation with ana-




Out of a total of 263 patients with pHPT, which were re-
ferred to the Department of Head and Neck Surgery at the
Copenhagen University Hospital Rigshospitalet in 2011
and 2012, 43 consecutive patients (16 %) with negative or
inconclusive sestamibi scan results were included in this
study (31 women and 12 men, aged 44– years, mean 65).
Three patients had previously undergone neck surgery, one
parathyroidectomy, one hemithyroidectomy and one total
thyroidectomy followed by postsurgical radioactive iodine
treatment. 16 patients had undergone ultrasound before
being referred to the Department of Head and Neck Sur-
gery, reporting changes suspicious for parathyroid adeno-
ma in six cases. In four patients, the ultrasound located the
abnormal gland on the correct side of the neck, of which
only one correct quadrant was reported.
4D-CT scan
4D-CT identified nodules suspicious for parathyroid ade-
noma in all 43 patients. In 31 cases, one nodule suspicious
for a solitary adenoma was found on 4D-CT (for example,
see Fig. 1). In seven cases, 4D-CT described two suspect
findings, with one much more suspicious than the other, so
that only the most suspicious was considered true. Only the
most suspect finding was considered as a true positive. In
four patients, the 4D-CT showed multiple ([2) suspicious
nodules on one side of the neck. Only one 4D-CT scan was
inconclusive with several questionable suspicious areas
bilaterally (see Table 1).
Surgery
The surgeons excised parathyroid glands with pathological
appearance in 42 of 43 patients. In one patient previously
treated with total thyroidectomy and radioactive iodine, no
abnormal parathyroid gland could be detected. One sus-
picious gland was removed in 67 % of patients, 2 glands
in 26 % of patients and 3 glands in 5 % of the patients
(see Table 1). IOPTH measurements were performed
during all surgical procedures, except one due to equip-
ment failure. In 95 % of the patients, there was found a
sufficient IOPTH drop after removal of all suspicious
glands indicating adequate resection of hyperfunctioning
parathyroid glands. There were no postsurgical compli-
cations such as hemorrhaging, wound infections or N.
recurrens paresis, as investigated by post surgical
fiberoptic laryngoscopy. In 31/43 (72 %) of the patients,
the extent of the surgical intervention could be reduced to
unilateral exploration.
Histopathological analysis and biochemistry
The histopathological examination of the surgically re-
sected parathyroid glands, confirmed the removal of a
single hyperfunctioning gland (HFPG) in 88 % (38/43) of
the patients. Two patients had multiglandular disease with
two hyperfunctioning glands. In two patients were all re-
moved parathyroid glands found to be histologically nor-
mal (see Table 1).
67 % of the surgically removed and histologically ver-
ified HFPGs were weighed after surgery with a median
weight of 542 mg (range 85–2048 mg). 61 % of these
HFPGs weighed less than 600 mg and 39 % more than
600 mg. 76 % of the HFPG weighing less than 600 mg and
91 % of the HFPG weighing more than 600 mg were on
preoperative 4D-CT found on the correct side of the neck
(see Table 2). All patients had presurgical mild hypercal-
cemia with slightly elevated plasma ionized serum calcium
levels (mean 1.47 mmol/L, range from 1.34 to 1.61 mmol/
L; normal 1.18–1.32 mmol/L) and no parathyroid hormone
suppression (presurgical PTH plasma concentration: mean
23.39 pmol/L, range from 5.55 to 76.00 pmol/L; normal
1.18–8.43 pmol/L). Postsurgical were 91 % patients nor-
mocalcaemic, with a follow-up time of at least 1 year. The
patient that underwent reoperation and one patient that got
removed one adenoma and two histologically normal
glands had relative hypoparathyroidism with mild
hypocalcaemia and PTH in the normal range after the last
surgery. The patient without finding of abnormal glands
and one of the patients that only got removed histologically
normal glands showed postoperative pHPT with hyper-
calcaemia and not suppressed PTH. The other patient that
only got removed a histologically normal parathyroid gland
was normocalcaemic after surgery, maybe because of
compromised blood supply to an adenoma.
Overall performance
Among the 43 patients undergoing 4D-CT imaging and
parathyroid surgery, where hyperfunctioning parathyroid
Eur Arch Otorhinolaryngol (2016) 273:1253–1259 1255
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glands were identified in 40 patients (solitary pathologic
glands in 38 patients and double hyperfunctioning glands
in 2 patients). 4D-CT imaging was clearly positive for
nodules in 42 patients. 32 solitary hyperfunctioning
parathyroid glands, had on preoperative 4D-CT, been de-
tected on the correct side of the neck (positive predictive
value of 76 %) and 21 of these in the correct quadrant
(positive predictive value 49 %) (see Table 3). In both
patients with double hyperfunctioning parathyroid glands,
one of the two pathological glands was identified in the
correct quadrant on 4D-CT.
Discussion
In our study, four-dimensional computed tomography (4D-
CT) was a potent instrument to localize most of the solitary
hyperfunctioning parathyroid glands (HFPGs) in patients
with primary hyperparathyroidism (pHPT) and negative
sestamibi scintigraphy, so that the majority (72 %) of pa-
tients included could be operated unilateral. Standard sur-
gical treatment of pHPT may routinely consist of bilateral
neck exploration, including exposing all four parathyroid
glands and excision of pathological appearing glands [5].
This invasive procedure may now be reduced to focused
unilateral neck surgical exploration [5]. This is possible
due to the performance of preoperative localization imag-
ing of hyperfunctioning and enlarged parathyroid glands in
combination with IOPTH measurement [5]. Standard
imaging modalities used in Denmark are currently ses-
tamibi scintigraphy, possibly in combination with SPECT
(single photon emission computed tomography), ultrasound
(US) and more infrequently computed tomography (CT).
According to literature, approximately 20 % of sestamibi
scans are false negative or inconclusive, despite bio-
chemical evidence of primary hyperparathyroidism [3, 7, 8,
11]. In our study, sestamibi scan was negative in 16 % of
the patients with pHPT referred to our surgical department.
Fig. 1 Example of preoperative
localization of pathological
parathyroid tissue with 4D-CT
scan. Demonstration of an area
suspicious for a parathyroid
adenoma (yellow arrows) in the
left upper quadrant in a axial,
b coronal and c sagittal plane,
and d, e three-dimensional
reconstruction




Number of suspect nodules on 4D-CT Inconclusive 1 2 [2
Number of patients 1 31 7 4
Number of glands excised per patient 0 1 2 3
Number of patients 1 29 11 2
Number histopathologically verified HFPGs excised per patient 0 1 2 [2
Number of patients 3 38 2 0
Table 2 Weight of hyperfunctioning parathyroid glands (HFPG) in
patients with primary hyperparathyroidism according to sidelocal-
ization on preoperative 4D-CT
Sidelocalization on 4D-CT
Correct Wrong
Weight of HFPG (mg) 542 ± 441 586 ± 464 204 ± 49
HFPG\600 mg 61 % 76 % 24 %
HFPG[600 mg 39 % 91 % 9 %
Data of the weight of HFPG shown are mean ± SD. Data for indi-
vidual parameters were not available in all cases; data for parathyroid
weight include 26 parathyroid adenomas
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4D-CT can be an ideal imaging alternative in these types of
cases.
Also other recent studies have shown that 4D-CT is of
value in the presurgical localization of hyperfunctioning
parathyroid glands (HFPGs) [6, 9, 12–18], with an accu-
racy of localization ranging from approximately 73–93 %
[19]. In our study, 84 % of the solitary pathological glands
could be localized with preoperative 4D-CT on the correct
side of the neck (PPV 76 %) and 55 % in the correct
quadrant (PPV 50 %). One possible reason for the lower
success in quadrant localization compared to side local-
ization may result from different head positioning between
CT examination and surgery. Another explanation could be
that 4D-CT examination, as ultrasound, is heavily depen-
dent upon the radiologist’s expertise. Depending on the
structure, size and position of the thyroid gland, determi-
nation of the precise location between the upper and lower
quadrant can be difficult.
4D-CT appears to be better than sestamibi scan and US
for small adenomas and in cases of mild hypercalcemia
[17, 20]. It has been described that the well-known in-
ability of sestamibi to consistently identify small HFPGs
may be due to the fact that the level of sestamibi uptake
corresponds to the size and weight of the parathyroid
glands, with a proposed cutoff of 600 mg proposed [20].
In our study, all patients had presurgical mild hypercal-
cemia with slightly elevated plasma ionized serum calci-
um levels (mean 1.47 mmol/L, range 1.34–1.61 mmol/L).
Median weight of the HFPGs that were excised in our
study was 542 mg with a range of 85–2,048 mg and 61 %
weighing less than 600 mg. In our study, 76 % of the
HFPG weighing less than 600 mg and 91 % of the HFPG
weighing more than 600 mg were found on 4D-CT on the
correct side of the neck. Thus, however side localization
was a little better in case of heavy adenomas, 4D-CT
could identify the majority of the small HFPG not found
on sestamibi scintigraphy. Despite this fact, we observed
that the evaluation of characteristic contrast enhancement
in very small adenomas can be difficult, possibly leading
to misinterpretation of lymph nodes as small adenomas on
4D-CT. But as this technique is new, the radiologist had
no possibility for obtaining prior experience in evaluation
of the 4D-CT. We can expect further improvement in the
sensitivity and specificity of this new modality compara-
ble with the increasing experience in interpreting 4D-CT
scans; however, an inter-reader comparison is suggested
with future evaluation of this technique.
The complication rates from surgery for pHPT increase
significantly in reoperation. Thus, 8 % N recurrens paresis
and 13 % permanent hypoparathyroidism are expected in
cases of reoperation [21–23]. Therefore, good preoperative
imaging and minimization of the extent of the surgical
intervention is important. In our study, there was no N.
recurrens paresis. Only one patient underwent reoperation
and had relative hypoparathyroidism with mild hypocal-
caemia and PTH within the normal range after the second
surgery. The overall success rate of[90 % in surgical in-
tervention corresponds to the best international results
[17, 24]. A potential surgical operator limitation of this
study is that the surgeons’ own visual assessment of the
parathyroid glands appearance determines if the gland is
removed or not. In some cases, the absences of a visual
Table 3 Results of preoperative localization diagnostic with 4D-CT scan of hyperfunctioning parathyroid glands according to surgical findings
in 43 patients with primary hyperparathyroidism
Surgical findings # Pt. 4D-CT findings





Solitary HPFG in patient
with double or no HFPG
No HPFG or
inconclusive
Solitary HFPG 38 32 (84 %)/21 (55 %) 5 (13 %)/16 (42 %) NA 1 (3 %)
Double HFPG 2 0 NA 2 (100 %) 0
No HFPG 3 NA NA 3 (100 %) 0
Total 43 32 (74 %)/21 (49 %) 5 (12 %)/16 (37 %) 5 (12 %) 1 (2 %)
Likelihood of positive 4D-CT
(4D-CTs with finding of HFPG/4D-CTs performed)
42/43 (98 %)
Likelihood of correct positive side/quadrant localization on 4D-CT 32/43 (74 %)
(4D-CTs with correct side/quadrant localization of HFPG/4D-CTs performed) 21/43 (49 %)
Positive predictive value of correct side/quadrant localization with 4D-CT 32/42 (76 %)
(4D-CTs with correct side/quadrant localization of HFPG/4D-CTs with finding of HFPG) 21/42 (50 %)
Italics values are the results regarding quadrant localization, while the numbers not in italics are those regarding side localization
HFPG hyperfunctioning parathyroid gland, #Pt. number of patients, NA not Applicable
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pathohistological appearance lead to nonexcision of the
tissue which had been indicated by the 4D-CT study sug-
gesting a pathological state smaller than can be seen by the
operator.
Regarding cost and time effort of 4D-CT compared to
sestamibi, the costs are approximately the same and 4D-CT
takes less time [25]. In a survey of economic conditions of
routine preoperative 4D-CT is concluded that the use of
4D-CT is considered to be a little more expensive than
surgery without using preoperative 4D-CT, but that more
patients can settle for minimally invasive procedures and
shorter hospitalization [26].
The estimated radiation dose in 4D-CT and sestamibi
scintigraphy are, depending on protocols in different in-
stitutions, respectively, 5.56–10.4 and 3.33–7.8 mSv [25,
27]. Although a 4D-CT study is considered to yield a
higher dose of radiation as compared to a sestamibi scan,
the average background radiation exposure of 3 mSv/y,
and added exposures of less than 15 mSv are considered
low risk for carcinogenesis [25]. However, the estimated
dose to the thyroid gland is much higher performing a 4D-
CT scan than a sestamibi scintigraphy [27]. Therefore, it is
currently recommended to perform 4D-CT only in excep-
tional cases in patients under 40 years of age. The youngest
patient in our study was 44 years. Newer CT scanners in-
troduced at Copenhagen University Hospital Gentofte
within the past year reduce radiation doses by up to 80 %
and establishment of these systems nationally will ensure
that the radiation dosages for all patients can be expected to
fall drastically within the near future.
Most previous studies evaluating 4D-CT imaging are
retrospective case studies and include a selected group of
patients. For the use 4D-CT as the primary preoperative
imaging modality, further prospective studies are required.
One prospective study comparing preoperative sestamibi
scan with 4D-CT is currently ongoing in Copenhagen at the
Department of Radiology and Nuclear Medicine at
University Hospital Gentofte in collaboration with
Department of Endocrinology at University Hospital Her-
lev and the Department of Head and Neck Surgery at
University Hospital Rigshospitalet.
Conclusion
In patients with primary hyperparathyroidism and negative
sestamibi scintigraphy, 4D-CT imaging before parathy-
roidectomy in combination with intraoperative parathyroid
hormone measurement can be considered as useful diag-
nostic tool to localize hyperfunctioning parathyroid glands,
supporting focused surgical intervention as presented in the
study. However, the use of 4D-CT as the primary imaging
modality will require further studies.
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